Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

RIT biomedical engineering researchers develop new separation technique for lab-on-chip devices to distinguish cells ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

The global CRISPR Market, valued at US$2.90 billion in 2024, is forecasted to grow at a robust CAGR of 11.2%, reaching ...

Presentation to Include Updated Data from 17 Sickle Cell Disease Patients in the Ongoing BEACON Phase 1/2 Clinical Trial ...

COPENHAGEN (Reuters) -Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral ...

Solgate - a biotech start-up based in Klosterneuburg, Austria - is accelerating the development of new therapies targeting solute carrier (SLC) transporters using automated liquid handling systems ...

Just as species adapt over generations, our body's cells accumulate DNA changes throughout life. Most are harmless, yet a few "driver" mutations give a cell a competitive edge and can spark cancer.

Clinical update on LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients ...

Organoids Market is Segmented by Type (Stem Cell Source, Tumor Cell Source), by Application (Biopharmaceutical Companies, ...

General Motors and battery partner LG Energy Solution are planning to start commercial production of lower-cost cells for ...